MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
169.55
+9.44
+5.90%
Pre Market: 169.55 0 0.00% 07:37 08/20 EDT
OPEN
165.70
PREV CLOSE
160.11
HIGH
169.68
LOW
164.50
VOLUME
11.14K
TURNOVER
344.82M
52 WEEK HIGH
169.68
52 WEEK LOW
87.78
TOTAL ASSET
10.92B
YTD YIELD
91.73%
1D
5D
1M
3M
1Y
5Y
1D
The 60/40 Portfolio Is 'Broken.' Here's How to Fix It.
Barron‘s · 5h ago
Healthy And Energized At New Highs
Seeking Alpha · 10h ago
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
Benzinga · 13h ago
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck
Seeking Alpha · 16h ago
Novavax Stock Moves Higher Wednesday: What's Driving the Action?
Benzinga · 19h ago
Flash Heard: Why Healthcare Is Partying Like It's Late 2020
The Wall Street Journal · 19h ago
Moderna surges on trial win for cancer shot; William Blair upgrades
Seeking Alpha · 21h ago
Healthcare ETFs rally as Moderna nearly doubles on melanoma win
Seeking Alpha · 22h ago
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 (TR) (1970)
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider